Literature DB >> 30774022

Hyperadrenocorticism Caused by a Pituitary Ganglioglioma in a Dog.

Hirokazu Ishino1, Susumu Takekoshi2, Takahiro Teshima3, Kazuyuki Uchida4, Iwao Sakonju1, Yasushi Hara5.   

Abstract

An 11-year-old castrated male Chihuahua dog was presented with complaints of polyuria, polydipsia, abdominal enlargement, and alopecia. Hyperadrenocorticism was diagnosed on the basis of clinical signs, blood tests, adrenocorticotropin-stimulation test results, and an elevated serum adrenocorticotropin concentration. Contrast-enhanced magnetic resonance imaging showed that the pituitary gland was enlarged, compatible with a pituitary macroadenoma. Pituitary-dependent hyperadrenocorticism was suspected, and transsphenoidal hypophysectomy was thus performed for complete resection of the tumor. After surgery, the serum adrenocorticotropin concentration normalized and the hyperadrenocorticism resolved. Histological and immunocytochemical analyses revealed a benign tumor composed of mature neuronal cells and glial cells, suggestive of a ganglioglioma with immunolabeling for adrenocorticotropin. Careful analysis of the resected tumor revealed no pituitary adenoma tissue. The clinical and histopathologic findings indicated that the ganglioglioma was directly responsible for the hyperadrenocorticism. This is the first case of hyperadrenocorticism caused by a ganglioglioma in a dog.

Entities:  

Keywords:  corticotroph; dog; ganglioglioma; hyperadrenocorticism; pituitary

Mesh:

Substances:

Year:  2019        PMID: 30774022     DOI: 10.1177/0300985819829530

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  2 in total

Review 1.  Transsphenoidal Surgery in Canines: Safety, Efficacy and Patient Selection.

Authors:  Yasushi Hara
Journal:  Vet Med (Auckl)       Date:  2020-01-14

2.  Ectopic Cushing's syndrome associated with a pheochromocytoma in a dog: a case report.

Authors:  Sungin Lee; Aeri Lee; Suh-Hyun Chai; Seulji Lee; Oh-Kyeong Kweon; Wan Hee Kim
Journal:  BMC Vet Res       Date:  2020-02-03       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.